Delivers Second Quarter Results in Line with and Above Guidance Ranges Revises Full Year 2025 Revenue Outlook and Reiterates ...

CNW/ - (TSX: KEY) ("Keyera") announced its second quarter financial results today, the highlights of which are included in ...

The Real Brokerage Inc. (NASDAQ: REAX) ("Real" or the "Company"), a leading real estate technology platform redefining the ...

Capital Program Guidance -- Full-year capital spend is expected between $66 million and $85 million for 2025, including $47 ...

Key Points GAAP revenue for Q2 2025 exceeded analyst estimates, reaching $1.23 billion compared to expectations of $1.21 billion. Advertising revenue fell 9.0%, mainly due to lower political ...

Net revenue for the fourth quarter of fiscal 2025 was $282.8 million. GAAP net loss for the fourth quarter of fiscal 2025 was $4.7 million, or a loss of $0.12 per basic share. Non-GAAP net income for ...

National Healthcare Properties, Inc. (Nasdaq: NHPAP / NHPBP) (the "Company"), a self-managed diversified healthcare real estate investment trust focusing on ...

Precision is advancing the final U.S. investigational new drug (IND)-enabling toxicology studies with an anticipated IND and/or clinical trial application (CTA) filing targeted by the end of 2025 with ...

The Company's second half of 2025 outlook assumes depreciation and amortization of $13.2 million, stock-based compensation expense of $5.0 million, other expense (net) of $5.3 million, restructuring ...

Commercial excellence continues to deliver, year-to-date volume growth up 84% over 20242025 Second Quarter HighlightsRevenue ...